{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:57Z","timestamp":1761630477105,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1053\/j.ajkd.2007.08.023","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T12:20:30Z","timestamp":1203682830000},"page":"127-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antibody-Mediated Rejection With a Striking Interstitial Monocyte\/Macrophage Infiltration in a Renal Allograft Under FTY720 Treatment"],"prefix":"10.1053","volume":"51","author":[{"given":"Banu","family":"Sis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Grynoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan G.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Solez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2007.08.023_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","article-title":"FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function","volume":"4","author":"Brinkmann","year":"2004","journal-title":"Am J Transplant"},{"issue":"suppl 2S","key":"10.1053\/j.ajkd.2007.08.023_bib2","doi-asserted-by":"crossref","first-page":"S544","DOI":"10.1016\/j.transproceed.2003.12.048","article-title":"FTY720: Early clinical experience","volume":"36","author":"Dragun","year":"2004","journal-title":"Transplant Proc"},{"issue":"suppl 2S","key":"10.1053\/j.ajkd.2007.08.023_bib3","doi-asserted-by":"crossref","first-page":"S531","DOI":"10.1016\/j.transproceed.2004.01.092","article-title":"FTY720: From bench to bedside","volume":"36","author":"Kahan","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1053\/j.ajkd.2007.08.023_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-6147(99)01419-4","article-title":"FTY720: A novel transplantation drug that modulates lymphocyte traffic rather than activation","volume":"21","author":"Brinkmann","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1053\/j.ajkd.2007.08.023_bib5","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing","volume":"160","author":"Chiba","year":"1998","journal-title":"J Immunol"},{"issue":"suppl 2S","key":"10.1053\/j.ajkd.2007.08.023_bib6","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1016\/j.transproceed.2004.01.061","article-title":"FTY720 immunomodulation: Optimism for improved transplant regimens","volume":"36","author":"Ferguson","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1053\/j.ajkd.2007.08.023_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007890-199601270-00006","article-title":"A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation","volume":"61","author":"Suzuki","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2007.08.023_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1432-2277.1998.tb00973.x","article-title":"Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation","volume":"11","author":"Xu","year":"1998","journal-title":"Transpl Int"},{"key":"10.1053\/j.ajkd.2007.08.023_bib9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.V1341073","article-title":"First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients","volume":"13","author":"Budde","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.08.023_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1034\/j.1600-6143.2003.00130.x","article-title":"Pharmacodynamics of single dose of the novel immunosuppressant FTY720 in stable renal patients","volume":"3","author":"Budde","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2007.08.023_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/01.TP.0000084822.01372.AC","article-title":"Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: A multicenter, randomized, placebo controlled, phase I study","volume":"76","author":"Kahan","year":"2003","journal-title":"Transplantation"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2007.08.023_bib12","first-page":"S243A","article-title":"FTY720 combined with Neoral and corticosteroids is effective and safe in prevention of acute rejection (AR) in renal allograft recipients (interim data)","volume":"1","author":"Tedesco-Silva","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2007.08.023_bib13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/01.TP.0000121761.02129.A6","article-title":"FTY720, a novel immunomodulator\u2014Efficacy and safety results from the first phase 2a study in de novo renal transplantation","volume":"79","author":"Tedesco-Silva","year":"2005","journal-title":"Transplantation"},{"issue":"suppl 4","key":"10.1053\/j.ajkd.2007.08.023_bib14","first-page":"S499A","article-title":"FTY720 with reduced cyclosporine exposure is efficacious in preventing rejection in renal transplantation: 12-Month preliminary results","volume":"18","author":"Walker","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2007.08.023_bib15","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/j.1600-6143.2006.01552.x","article-title":"FTY720 versus MMF with cyclosporine in de novo renal transplantation: A 1-year, randomized controlled trial in Europe and Australasia","volume":"6","author":"Salvadori","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2007.08.023_bib16","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/01.tp.0000251718.95622.b3","article-title":"Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation","volume":"82","author":"Tedesco-Silva","year":"2006","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2007.08.023_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014An addition to the Banff \u201997 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2007.08.023_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.08.023_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.TP.0000083507.67995.13","article-title":"Macrophages act as effectors of tissue damage in acute renal allograft rejection","volume":"76","author":"Jose","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2007.08.023_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.TP.0000071362.99021.D9","article-title":"Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)","volume":"76","author":"Kirk","year":"2003","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2007.08.023_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.CIR.0000152101.41037.AB","article-title":"KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts","volume":"111","author":"Shimizu","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2007.08.023_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.281.5373.96","article-title":"Visualization of specific B and T lymphocyte interactions in the lymph node","volume":"281","author":"Garside","year":"1998","journal-title":"Science"},{"key":"10.1053\/j.ajkd.2007.08.023_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nri1334","article-title":"T-Cell-B-cell cooperation","volume":"4","author":"Mitchison","year":"2004","journal-title":"Nat Rev Immunol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638607013558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638607013558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:49:26Z","timestamp":1759456166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638607013558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0272638607013558"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.08.023","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-Mediated Rejection With a Striking Interstitial Monocyte\/Macrophage Infiltration in a Renal Allograft Under FTY720 Treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}